Skip to main content
. 2019 Mar 14;19(5):3527–3536. doi: 10.3892/mmr.2019.10034

Figure 2.

Figure 2.

Effects of carvedilol on cardiomyocyte viability and miR-1 expression. (A) Effects of 10 µM carvedilol on cardiomyocyte viability in the presence of 100 µM H2O2 for 24 h, as determined by an MTT assay. (B) miR-1 expression in myocardial tissue as determined by RT-qPCR, which was normalized to U6. (C) miR-1 expression in cardiomyocytes as determined by RT-qPCR, which was normalized to U6. All data are presented as relative levels. *P<0.05 vs. Sham or Con; #P<0.05 vs. MI or H2O2. miR, microRNA; RT-qPCR, reverse transcription quantitative polymerase chain reaction; car, carvedilol; con, control; MI, myocardial infarction.